# Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1

> **NCT01353924** · PHASE1 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 20 (estimated)

## Conditions studied

- Allergy

## Interventions

- **BIOLOGICAL:** Bet v 1aF1-Alum + Bet v 1aF2-Alum
- **BIOLOGICAL:** Alum-Placebo

## Key facts

- **NCT ID:** NCT01353924
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2012-08
- **Final completion:** 2013-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-05-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01353924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01353924, "Immune Response of Individuals Vaccinated With Hypoallergenic Derivatives of the Major Birch Pollen Allergen, Bet v 1". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01353924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*